| Bioactivity | BDCRB is a selective Human cytomegalovirus (HCMV) inhibitor through blocking the maturational cleavage of high-molecular-weight DNA. BDCRB shows a mean IC50 of 0.03 μM for viral yield at 72 h postinfection[1]. |
| CAS | 142356-43-2 |
| Formula | C12H11BrCl2N2O4 |
| Molar Mass | 398.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Biron KK, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72. |
BDCRB
CAS: 142356-43-2 F: C12H11BrCl2N2O4 W: 398.04
BDCRB is a selective Human cytomegalovirus (HCMV) inhibitor through blocking the maturational cleavage of high-molecular
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.